| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.36 | 7e-23 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.44 | 4e-17 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.36 | 2e-13 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 3e-05 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |